Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty
PurposeGonadotropin-releasing hormone agonist (GnRHa) is used as a therapeutic agent for central precocious puberty (CPP); however, increased obesity may subsequently occur. This study compared body mass index (BMI) and insulin resistance during the first year of GnRHa treatment for CPP.MethodsPatie...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Korean Society of Pediatric Endocrinology
2017-03-01
|
| Seri Bilgileri: | Annals of Pediatric Endocrinology & Metabolism |
| Konular: | |
| Online Erişim: | http://e-apem.org/upload/pdf/apem-22-27.pdf |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|